Roland Frösing

Roland Frösing currently works at Marstrands Dyk & Skeppshandel AB, as Chairman, Neuroplastisk Centrum I Marstrand AB, as Chairman, Marstrandsföretagarna & Co. Ekonomisk Förening, as Chairman, VIP-Hälsan AB, as Director, Bostadsrättsföreningen Skäreleja-Varvet, as Director, Glycorex Transplantation AB, as Director from 2024, Dykläkarna I Göteborg Handelsbolag, as Partner, and Rewell Medical AB, as Chief Medical Officer.
Dr. Frösing also formerly worked at Rls Global AB, as Chief Executive Officer & Director, MediWound Ltd., as Director-European Medical from 2015 to 2022, Pfizer Health AB, as Medical Director, Mölnlycke Health Care AB, as Director-Global Medical from 2008 to 2015, Pfizer AB, as Medical Director from 1999 to 2004, Astellas Pharma AB, as Director-Nordic Medical from 2005 to 2008, and S2Medical AB, as Independent Director from 2018 to 2021.
Dr. Frösing received his doctorate degree from the University of Gothenburg.